Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia

Por Johnson, Amy J., Lucas, David M., Muthusamy, Natarajan, Smith, Lisa L., Edwards, Ryan B., De Lay, Michael D., Croce, Carlo M., Grever, Michael R., Byrd, John C.
Publicado em 2006

Standard Pentostatin Dose Reductions in Renal Insufficiency are not Adequate: Selected Patients with Steroid-Refractory Acute Graft-versus-Host Disease

Por Poi, Ming J., Hofmeister, Craig C., Johnston, Jeffrey S., Edwards, Ryan B., Jansak, Buffy S., Lucas, David M., Farag, Sherif S., Dalton, James T., Devine, Steven M., Grever, Michael R., Phelps, Mitch A.
Publicado em 2013

Dual Targeting of the Cyclin/Rb/E2F and Mitochondrial Pathways in Mantle Cell Lymphoma with the Translation Inhibitor Silvestrol

Por Alinari, Lapo, Prince, Courtney J., Edwards, Ryan B., Towns, William, Mani, Rajeswaran, Lehman, Amy, Zhang, Xiaoli, Jarjoura, David, Pan, Li, Kinghorn, A. Douglas, Grever, Michael R., Baiocchi, Robert A., Lucas, David M.
Publicado em 2012

Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells

Por Gupta, Sneha V., Sass, Ellen J., Davis, Melanie E., Edwards, Ryan B., Lozanski, Gerard, Heerema, Nyla A., Lehman, Amy, Zhang, Xiaoli, Jarjoura, David, Byrd, John C., Pan, Li, Chan, Kenneth K., Kinghorn, A. Douglas, Phelps, Mitch A., Grever, Michael R., Lucas, David M.
Publicado em 2011

The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo

Por Lucas, David M., Edwards, Ryan B., Lozanski, Gerard, West, Derek A., Shin, Jungook D., Vargo, Melissa A., Davis, Melanie E., Rozewski, Darlene M., Johnson, Amy J., Su, Bao-Ning, Goettl, Virginia M., Heerema, Nyla A., Lin, Thomas S., Lehman, Amy, Zhang, Xiaoli, Jarjoura, David, Newman, David J., Byrd, John C., Kinghorn, A. Douglas, Grever, Michael R.
Publicado em 2009

The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo

Por Lucas, David M., Alinari, Lapo, West, Derek A., Davis, Melanie E., Edwards, Ryan B., Johnson, Amy J., Blum, Kristie A., Hofmeister, Craig C., Freitas, Michael A., Parthun, Mark R., Wang, Dasheng, Lehman, Amy, Zhang, Xiaoli, Jarjoura, David, Kulp, Samuel K., Croce, Carlo M., Grever, Michael R., Chen, Ching-Shih, Baiocchi, Robert A., Byrd, John C.
Publicado em 2010